FIELD: medicine, oncology.
SUBSTANCE: method involves carrying out the preliminary catheterization of larynx artery and the following intra-arterial chemotherapy by administration of cisplatin as 6 h infusion of 80-100 ml of 0.0025% solution from 1-st to 4-th day of treatment in the total dose 100 mg/m2, 5-fluorouracil as 3 h infusion of 20 ml of 5% solution from 5-th to 7-th day of treatment in the total dose 3 g. After termination of chemotherapy in 2-3 weeks after arresting adverse reactions in tumor regression above 50% the larynx resection is carried out and in regression less 50% - laryngoectomy. In 3-4 weeks after surgery operation the distance radiation therapy is carried out in a single irradiation dose 2.0 Gr in irradiation regimen 5 times per a week and in the total dose 40-46 Gr in laryngoectomy and 60-66 Gr in organ-retaining surgery operation depending on the stage of the primary process. Method provides the functional rehabilitation of patients and decreasing expression and amount of total complications of complex therapy based on step-by-step carrying out the treatment. Invention can be used in treatment of patients with locally spread squamous larynx cancer.
EFFECT: improved method of treatment.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH RECURRENT THORACIC ESOPHAGUS CANCER IN ESOPHAGEAL-GASTRIC ANASTOMOSIS | 2019 |
|
RU2728192C1 |
METHOD FOR TREATING PATIENTS FOR LOCALLY SPREAD CARCINOMA CASES LOCALIZED IN MUCOUS MEMBRANE OF ORAL CAVITY AND ORAL DIVISION OF THE PHARYNX | 2003 |
|
RU2240117C1 |
METHOD OF PERSONALIZED INTRA-ARTERIAL CHEMOTHERAPEUTIC AGENT INFUSION DURING TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2015 |
|
RU2612095C1 |
METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
METHOD FOR APPLYING COMBINED TREATMENT OF PATIENTS FOR NON-SMALL-CELL PULMONARY CANCER OF III STAGE | 2004 |
|
RU2270706C2 |
METHOD OF ORGAN-PRESERVING TREATMENT OF SQUAMOUS CELL CARCINOMA OF ORAL MUCOSA cT1N0M0 WITH DEPTH OF TUMOUR INVASION UP TO 5 mm | 2023 |
|
RU2824427C2 |
METHOD FOR TREATING PATIENTS WITH LOCALLY METASTASING FORMS OF CANCER AT LOCALIZATION IN MUCOSAL AREA OF PHARYNGEAL ORAL DEPARTMENT | 2003 |
|
RU2255734C1 |
METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OPERABLE OESOPHAGEAL CANCER | 2009 |
|
RU2424007C1 |
METHOD OF COMBINED TREATMENT OF NON-SMALL CELL CANCER OF LUNG OF III STAGE | 2007 |
|
RU2340336C1 |
METHOD FOR INTEGRATED TREATMENT OF LOCALLY ADVANCED THORACIC OESOPHAGEAL CARCINOMA | 2011 |
|
RU2459643C1 |
Authors
Dates
2007-07-27—Published
2005-06-02—Filed